{"count": 9, "results": [{"_id": "35830548", "pmid": 35830548, "title": "Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis.", "journal": "J Clin Gastroenterol", "authors": ["Zhang H", "Zhang Q", "Li S", "Xie B"], "date": "2022-09-01T00:00:00Z", "doi": "10.1097/MCG.0000000000001732", "meta_date_publication": "2022 Sep 1", "meta_volume": "56", "meta_issue": "8", "meta_pages": "e303-e312", "score": 50259.96, "text_hl": "CONCLUSIONS: The use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@cirrhotic@@@ @SPECIES_9606 @@@patients@@@ lowers mortality rates by suppressing incidences of fatal @DISEASE_Hemorrhage @DISEASE_MESH:D006470 @@@bleeding@@@.", "citations": {"NLM": "Zhang H, Zhang Q, Li S, Xie B. Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis. J Clin Gastroenterol. 2022 Sep 1;56(8):e303-e312. PMID: 35830548", "BibTeX": "@article{35830548, title={Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis.}, author={Zhang H and Zhang Q and Li S and Xie B}, journal={J Clin Gastroenterol}, volume={56}, number={8}, pages={e303-e312}}"}}, {"_id": "32079861", "pmid": 32079861, "title": "Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.", "journal": "Am J Gastroenterol", "authors": ["Vijayaraghavan R", "Jindal A", "Arora V", "Choudhary A", "Kumar G", "Sarin SK"], "date": "2020-05-01T00:00:00Z", "doi": "10.14309/ajg.0000000000000551", "meta_date_publication": "2020 May", "meta_volume": "115", "meta_issue": "5", "meta_pages": "729-737", "score": 50258.35, "text_hl": "We studied whether addition of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@carvedilol@@@ in @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@cirrhotic@@@ @SPECIES_9606 @@@patients@@@ for primary prophylaxis improves the hemodynamic response. ", "citations": {"NLM": "Vijayaraghavan R, Jindal A, Arora V, Choudhary A, Kumar G, Sarin SK. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial. Am J Gastroenterol. 2020 May;115(5):729-737. PMID: 32079861", "BibTeX": "@article{32079861, title={Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.}, author={Vijayaraghavan R and Jindal A and Arora V and Choudhary A and Kumar G and Sarin SK}, journal={Am J Gastroenterol}, volume={115}, number={5}, pages={729-737}}"}}, {"_id": "33204591", "pmid": 33204591, "pmcid": "PMC7653246", "title": "Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature", "journal": "JIMD Rep", "authors": ["Yaplito-Lee J", "Pai G", "Hardikar W", "Hong KM", "Pitt J", "Marum J", "Amor DJ"], "date": "2020-08-18T00:00:00Z", "doi": "10.1002/jmd2.12158", "meta_date_publication": "2020 Nov", "meta_volume": "56", "meta_issue": "1", "meta_pages": "14-19", "score": 50250.992, "text_hl": "Based on a previous case report, 5  we used @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ initially at a dose of 5 mg daily (0.2 mg/kg/day). ", "citations": {"NLM": "Yaplito-Lee J, Pai G, Hardikar W, Hong KM, Pitt J, Marum J, Amor DJ. Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature JIMD Rep. 2020 Nov;56(1):14-19. PMID: 33204591", "BibTeX": "@article{33204591, title={Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature}, author={Yaplito-Lee J and Pai G and Hardikar W and Hong KM and Pitt J and Marum J and Amor DJ}, journal={JIMD Rep}, volume={56}, number={1}, pages={14-19}}"}}, {"_id": "33771685", "pmid": 33771685, "pmcid": "PMC8422958", "title": "SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation", "journal": "Contemp Clin Trials", "authors": ["Kaplan DE", "Mehta R", "Garcia-Tsao G", "Albrecht J", "Aytaman A", "Baffy G", "Bajaj J", "Hernaez R", "Hunt K", "Ioannou G", "Johnson K", "Kanwal F", "Lee TH", "Monto A", "Pandya P", "Schaubel D", "Taddei TH"], "date": "2021-05-01T00:00:00Z", "doi": "10.1016/j.cct.2021.106367", "meta_date_publication": "2021 May", "meta_volume": "104", "meta_issue": "", "meta_pages": "106367", "score": 50243.98, "text_hl": "This proposal aims to extend these findings to demonstrate that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduces incident @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@hepatic decompensation@@@ events among @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@cirrhotic@@@ @SPECIES_9606 @@@patients@@@ at high risk for @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@hepatic decompensation@@@.", "citations": {"NLM": "Kaplan DE, Mehta R, Garcia-Tsao G, Albrecht J, Aytaman A, Baffy G, Bajaj J, Hernaez R, Hunt K, Ioannou G, Johnson K, Kanwal F, Lee TH, Monto A, Pandya P, Schaubel D, Taddei TH. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation Contemp Clin Trials. 2021 May;104():106367. PMID: 33771685", "BibTeX": "@article{33771685, title={SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation}, author={Kaplan DE and Mehta R and Garcia-Tsao G and Albrecht J and Aytaman A and Baffy G and Bajaj J and Hernaez R and Hunt K and Ioannou G and Johnson K and Kanwal F and Lee TH and Monto A and Pandya P and Schaubel D and Taddei TH}, journal={Contemp Clin Trials}, volume={104}, pages={106367}}"}}, {"_id": "17335931", "pmid": 17335931, "title": "Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.", "journal": "J Hepatol", "authors": ["Abraldes JG", "Rodríguez-Vilarrupla A", "Graupera M", "Zafra C", "García-Calderó H", "García-Pagán JC", "Bosch J"], "date": "2007-06-01T00:00:00Z", "doi": "10.1016/j.jhep.2007.01.020", "meta_date_publication": "2007 Jun", "meta_volume": "46", "meta_issue": "6", "meta_pages": "1040-6", "score": 50080.13, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment improves @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@liver sinusoidal endothelial dysfunction@@@ in @CHEMICAL_Carbon_Tetrachloride @CHEMICAL_MESH:D002251 @@@CCl4@@@ @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@cirrhotic@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Abraldes JG, Rodríguez-Vilarrupla A, Graupera M, Zafra C, García-Calderó H, García-Pagán JC, Bosch J. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J Hepatol. 2007 Jun;46(6):1040-6. PMID: 17335931", "BibTeX": "@article{17335931, title={Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.}, author={Abraldes JG and Rodríguez-Vilarrupla A and Graupera M and Zafra C and García-Calderó H and García-Pagán JC and Bosch J}, journal={J Hepatol}, volume={46}, number={6}, pages={1040-6}}"}}, {"_id": "23184571", "pmid": 23184571, "title": "Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.", "journal": "Hepatology", "authors": ["La Mura V", "Pasarín M", "Meireles CZ", "Miquel R", "Rodríguez-Vilarrupla A", "Hide D", "Gracia-Sancho J", "García-Pagán JC", "Bosch J", "Abraldes JG"], "date": "2013-03-01T00:00:00Z", "doi": "10.1002/hep.26127", "meta_date_publication": "2013 Mar", "meta_volume": "57", "meta_issue": "3", "meta_pages": "1172-81", "score": 50058.438, "text_hl": "This was associated with reduced @GENE_NOS3 @GENE_24600 @@@eNOS@@@ phosphorylation and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@liver inflammation@@@. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ after @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@ challenge did not prevent the increase in baseline portal perfusion pressure, but attenuated the development of @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@sinusoidal endothelial dysfunction@@@. ", "citations": {"NLM": "La Mura V, Pasarín M, Meireles CZ, Miquel R, Rodríguez-Vilarrupla A, Hide D, Gracia-Sancho J, García-Pagán JC, Bosch J, Abraldes JG. Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction. Hepatology. 2013 Mar;57(3):1172-81. PMID: 23184571", "BibTeX": "@article{23184571, title={Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.}, author={La Mura V and Pasarín M and Meireles CZ and Miquel R and Rodríguez-Vilarrupla A and Hide D and Gracia-Sancho J and García-Pagán JC and Bosch J and Abraldes JG}, journal={Hepatology}, volume={57}, number={3}, pages={1172-81}}"}}, {"_id": "26321186", "pmid": 26321186, "title": "Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.", "journal": "Dig Liver Dis", "authors": ["Pollo-Flores P", "Soldan M", "Santos UC", "Kunz DG", "Mattos DE", "da Silva AC", "Marchiori RC", "Rezende GF"], "date": "2015-11-01T00:00:00Z", "doi": "10.1016/j.dld.2015.07.156", "meta_date_publication": "2015 Nov", "meta_volume": "47", "meta_issue": "11", "meta_pages": "957-63", "score": 50057.266, "text_hl": "AIM: We evaluated the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on hepatic venous pressure gradient (HVPG) and azygos vein blood flow in @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@cirrhotic@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Pollo-Flores P, Soldan M, Santos UC, Kunz DG, Mattos DE, da Silva AC, Marchiori RC, Rezende GF. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. Dig Liver Dis. 2015 Nov;47(11):957-63. PMID: 26321186", "BibTeX": "@article{26321186, title={Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.}, author={Pollo-Flores P and Soldan M and Santos UC and Kunz DG and Mattos DE and da Silva AC and Marchiori RC and Rezende GF}, journal={Dig Liver Dis}, volume={47}, number={11}, pages={957-63}}"}}, {"_id": "21112949", "pmid": 21112949, "title": "Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver.", "journal": "Gut", "authors": ["Gracia-Sancho J", "Russo L", "García-Calderó H", "García-Pagán JC", "García-Cardeña G", "Bosch J"], "date": "2011-04-01T00:00:00Z", "doi": "10.1136/gut.2010.220913", "meta_date_publication": "2011 Apr", "meta_volume": "60", "meta_issue": "4", "meta_pages": "517-24", "score": 50055.902, "text_hl": "Additionally, @GENE_KLF2 @GENE_306330 @@@KLF2@@@ expression was determined in liver sections, in freshly-isolated hepatic endothelial cells, and in livers from @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@cirrhotic@@@ animals. ", "citations": {"NLM": "Gracia-Sancho J, Russo L, García-Calderó H, García-Pagán JC, García-Cardeña G, Bosch J. Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut. 2011 Apr;60(4):517-24. PMID: 21112949", "BibTeX": "@article{21112949, title={Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver.}, author={Gracia-Sancho J and Russo L and García-Calderó H and García-Pagán JC and García-Cardeña G and Bosch J}, journal={Gut}, volume={60}, number={4}, pages={517-24}}"}}, {"_id": "31440376", "pmid": 31440376, "pmcid": "PMC6675529", "title": "Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease", "journal": "Aging Dis", "authors": ["Maeso-Díaz R", "Ortega-Ribera M", "Lafoz E", "Lozano JJ", "Baiges A", "Francés R", "Albillos A", "Peralta C", "García-Pagán JC", "Bosch J", "Cogger VC", "Gracia-Sancho J"], "date": "2019-08-01T00:00:00Z", "doi": "10.14336/AD.2019.0127", "meta_date_publication": "2019 Aug", "meta_volume": "10", "meta_issue": "4", "meta_pages": "684-698", "score": 50041.414, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ improves the hepatocyte phenotype in aged @<m>DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension</m> @DISEASE_MESH:D000094724 @@@cirrhotic@@@ rats", "citations": {"NLM": "Maeso-Díaz R, Ortega-Ribera M, Lafoz E, Lozano JJ, Baiges A, Francés R, Albillos A, Peralta C, García-Pagán JC, Bosch J, Cogger VC, Gracia-Sancho J. Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease Aging Dis. 2019 Aug;10(4):684-698. PMID: 31440376", "BibTeX": "@article{31440376, title={Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease}, author={Maeso-Díaz R and Ortega-Ribera M and Lafoz E and Lozano JJ and Baiges A and Francés R and Albillos A and Peralta C and García-Pagán JC and Bosch J and Cogger VC and Gracia-Sancho J}, journal={Aging Dis}, volume={10}, number={4}, pages={684-698}}"}}]}